Respirology

Cover image for Vol. 15 Issue 1

January 2010

Volume 15, Issue 1

Pages 1–190

  1. EDITORIALS

    1. Top of page
    2. EDITORIALS
    3. INVITED REVIEW SERIES: COMPLICATIONS IN LUNG PROCEDURES
    4. INVITED REVIEW SERIES: PULMONARY FIBROSIS
    5. INVITED REVIEW SERIES: TUBERCULOSIS
    6. THINK TANK REVIEW
    7. PRO/CON DEBATE
    8. REVIEWS
    9. ORIGINAL ARTICLES
    10. SHORT COMMUNICATIONS
    11. TECHNICAL REPORT
    12. YEAR IN REVIEW
    13. CASE REPORTS
    14. FORTHCOMING MEETINGS/JOURNAL STATISTICS
    15. ACKNOWLEDGEMENTS
    1. You have free access to this content
    2. You have free access to this content
      Iodopovidone as a pleurodesis agent: Setting standards for clinical pleural research (pages 4–5)

      Andreas H. Diacon

      Version of Record online: 27 DEC 2009 | DOI: 10.1111/j.1440-1843.2009.01654.x

      Corrected by:

      ERRATUM

      Vol. 15, Issue 3, 581, Version of Record online: 29 MAR 2010

  2. INVITED REVIEW SERIES: COMPLICATIONS IN LUNG PROCEDURES

    1. Top of page
    2. EDITORIALS
    3. INVITED REVIEW SERIES: COMPLICATIONS IN LUNG PROCEDURES
    4. INVITED REVIEW SERIES: PULMONARY FIBROSIS
    5. INVITED REVIEW SERIES: TUBERCULOSIS
    6. THINK TANK REVIEW
    7. PRO/CON DEBATE
    8. REVIEWS
    9. ORIGINAL ARTICLES
    10. SHORT COMMUNICATIONS
    11. TECHNICAL REPORT
    12. YEAR IN REVIEW
    13. CASE REPORTS
    14. FORTHCOMING MEETINGS/JOURNAL STATISTICS
    15. ACKNOWLEDGEMENTS
    1. You have free access to this content
  3. INVITED REVIEW SERIES: PULMONARY FIBROSIS

    1. Top of page
    2. EDITORIALS
    3. INVITED REVIEW SERIES: COMPLICATIONS IN LUNG PROCEDURES
    4. INVITED REVIEW SERIES: PULMONARY FIBROSIS
    5. INVITED REVIEW SERIES: TUBERCULOSIS
    6. THINK TANK REVIEW
    7. PRO/CON DEBATE
    8. REVIEWS
    9. ORIGINAL ARTICLES
    10. SHORT COMMUNICATIONS
    11. TECHNICAL REPORT
    12. YEAR IN REVIEW
    13. CASE REPORTS
    14. FORTHCOMING MEETINGS/JOURNAL STATISTICS
    15. ACKNOWLEDGEMENTS
    1. You have free access to this content
      Current clinical trials for the treatment of idiopathic pulmonary fibrosis (pages 19–31)

      Ross C. KLINGSBERG, Steven E. MUTSAERS and Joseph A. LASKY

      Version of Record online: 27 DEC 2009 | DOI: 10.1111/j.1440-1843.2009.01672.x

  4. INVITED REVIEW SERIES: TUBERCULOSIS

    1. Top of page
    2. EDITORIALS
    3. INVITED REVIEW SERIES: COMPLICATIONS IN LUNG PROCEDURES
    4. INVITED REVIEW SERIES: PULMONARY FIBROSIS
    5. INVITED REVIEW SERIES: TUBERCULOSIS
    6. THINK TANK REVIEW
    7. PRO/CON DEBATE
    8. REVIEWS
    9. ORIGINAL ARTICLES
    10. SHORT COMMUNICATIONS
    11. TECHNICAL REPORT
    12. YEAR IN REVIEW
    13. CASE REPORTS
    14. FORTHCOMING MEETINGS/JOURNAL STATISTICS
    15. ACKNOWLEDGEMENTS
    1. You have free access to this content
  5. THINK TANK REVIEW

    1. Top of page
    2. EDITORIALS
    3. INVITED REVIEW SERIES: COMPLICATIONS IN LUNG PROCEDURES
    4. INVITED REVIEW SERIES: PULMONARY FIBROSIS
    5. INVITED REVIEW SERIES: TUBERCULOSIS
    6. THINK TANK REVIEW
    7. PRO/CON DEBATE
    8. REVIEWS
    9. ORIGINAL ARTICLES
    10. SHORT COMMUNICATIONS
    11. TECHNICAL REPORT
    12. YEAR IN REVIEW
    13. CASE REPORTS
    14. FORTHCOMING MEETINGS/JOURNAL STATISTICS
    15. ACKNOWLEDGEMENTS
    1. You have free access to this content
      Lung cancer: Progress in diagnosis, staging and therapy (pages 44–50)

      Stephen G. SPIRO, Nichole T. TANNER, Gerard A. SILVESTRI, Sam M. JANES, Eric LIM, Johan F. VANSTEENKISTE and Robert PIRKER

      Version of Record online: 27 DEC 2009 | DOI: 10.1111/j.1440-1843.2009.01674.x

  6. PRO/CON DEBATE

    1. Top of page
    2. EDITORIALS
    3. INVITED REVIEW SERIES: COMPLICATIONS IN LUNG PROCEDURES
    4. INVITED REVIEW SERIES: PULMONARY FIBROSIS
    5. INVITED REVIEW SERIES: TUBERCULOSIS
    6. THINK TANK REVIEW
    7. PRO/CON DEBATE
    8. REVIEWS
    9. ORIGINAL ARTICLES
    10. SHORT COMMUNICATIONS
    11. TECHNICAL REPORT
    12. YEAR IN REVIEW
    13. CASE REPORTS
    14. FORTHCOMING MEETINGS/JOURNAL STATISTICS
    15. ACKNOWLEDGEMENTS
    1. You have free access to this content
      Public health management of pandemic (H1N1) 2009 infection in Australia: A failure! (pages 51–56)

      Grant W. WATERER, David S. HUI and Christine R. JENKINS

      Version of Record online: 27 DEC 2009 | DOI: 10.1111/j.1440-1843.2009.01675.x

  7. REVIEWS

    1. Top of page
    2. EDITORIALS
    3. INVITED REVIEW SERIES: COMPLICATIONS IN LUNG PROCEDURES
    4. INVITED REVIEW SERIES: PULMONARY FIBROSIS
    5. INVITED REVIEW SERIES: TUBERCULOSIS
    6. THINK TANK REVIEW
    7. PRO/CON DEBATE
    8. REVIEWS
    9. ORIGINAL ARTICLES
    10. SHORT COMMUNICATIONS
    11. TECHNICAL REPORT
    12. YEAR IN REVIEW
    13. CASE REPORTS
    14. FORTHCOMING MEETINGS/JOURNAL STATISTICS
    15. ACKNOWLEDGEMENTS
    1. You have free access to this content
      Fractional exhaled nitric oxide in asthma: an update (pages 57–70)

      Alessandra SANDRINI, D. Robin TAYLOR, Paul S. THOMAS and Deborah H. YATES

      Version of Record online: 16 SEP 2009 | DOI: 10.1111/j.1440-1843.2009.01616.x

    2. You have free access to this content
      Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA): Applications in chest disease (pages 71–79)

      Andrew R.L. MEDFORD, Jonathan A. BENNETT, Catherine M. FREE and Sanjay AGRAWAL

      Version of Record online: 5 NOV 2009 | DOI: 10.1111/j.1440-1843.2009.01652.x

  8. ORIGINAL ARTICLES

    1. Top of page
    2. EDITORIALS
    3. INVITED REVIEW SERIES: COMPLICATIONS IN LUNG PROCEDURES
    4. INVITED REVIEW SERIES: PULMONARY FIBROSIS
    5. INVITED REVIEW SERIES: TUBERCULOSIS
    6. THINK TANK REVIEW
    7. PRO/CON DEBATE
    8. REVIEWS
    9. ORIGINAL ARTICLES
    10. SHORT COMMUNICATIONS
    11. TECHNICAL REPORT
    12. YEAR IN REVIEW
    13. CASE REPORTS
    14. FORTHCOMING MEETINGS/JOURNAL STATISTICS
    15. ACKNOWLEDGEMENTS
    1. Nerve growth factor mediated SH2-Bβ/Akt signal pathway activated in allergic airway challenge in mice (pages 80–87)

      Yuli LIU, Baohui ZHANG, Shuna ZHANG, Jinping QI, Zhenghong ZHANG, Libo LIU and Xiubin FANG

      Version of Record online: 23 NOV 2009 | DOI: 10.1111/j.1440-1843.2009.01648.x

      The study investigated the effects of NGF and SH2-Bβ on Akt activation during allergic airway challenge using BALB/c mice sensitized with ovalbumin. The results indicate that the SH2-Bβ regulation of Akt participates in the NGF-mediated allergic airway response and blocking NGF and SH2-Bβ may be a potential therapeutic approach for asthma.

    2. Clinical characteristics of acute respiratory deterioration in pulmonary fibrosis associated with lung cancer following anti-cancer therapy (pages 88–92)

      Kazutoshi ISOBE, Yoshinobu HATA, Susumu SAKAMOTO, Yujiro TAKAI, Kazutoshi SHIBUYA and Sakae HOMMA

      Version of Record online: 30 NOV 2009 | DOI: 10.1111/j.1440-1843.2009.01666.x

      This retrospective study investigated the risk factors for acute respiratory deterioration following anti-cancer therapy in 41 patients with pulmonary fibrosis and lung cancer. Acute respiratory deterioration occurred in 24% of patients following anti-cancer therapy (surgical resection and chemotherapy). Smoking was an independent risk factor for acute respiratory deterioration.

    3. Clinical characteristics of Japanese patients with familial obstructive sleep apnoea syndrome (pages 93–98)

      Akira MATSUO, Yuichi INOUE, Satoru TSUIKI, Minori ENOMOTO, Kazuyoshi NAMBA and Hiroshige CHIBA

      Version of Record online: 30 NOV 2009 | DOI: 10.1111/j.1440-1843.2009.01668.x

      The clinical and cephalographic characteristics of Japanese patients with familial OSAS, non-familial OSAS and healthy controls were compared. Patients with familial OSAS had a lower mean BMI, earlier onset of habitual snoring and minor anomalies of craniofacial morphology.

    4. Fluorescence optical fibre sensor provides accurate continuous oxygen detection in rabbit model with acute lung injury (pages 99–106)

      Yuehong WANG, Sheng MENG, Yuanlin SONG, Wei ZHONG, Jinjun JIANG, Shujing CHEN and Chunxue BAI

      Version of Record online: 30 NOV 2009 | DOI: 10.1111/j.1440-1843.2009.01667.x

      This study tested the sensitivity, reproducibility and stability of a fluorescence oxygen sensor in a rabbit model. The oxygen sensor showed high accuracy and stability for continuous monitoring of PaO2 in normal animals, in animals with acute lung injury and in animals with electrolyte disturbance.

    5. Gender differences in asthma prevalence: Variations with socioeconomic disadvantage (pages 107–114)

      Catherine R. CHITTLEBOROUGH, Anne W. TAYLOR, Eleonora DAL GRANDE, Tiffany K. GILL, Janet F. GRANT, Robert J. ADAMS, David H. WILSON, Richard E. RUFFIN and On Behalf of The North West Adelaide Health Study Team

      Version of Record online: 22 OCT 2009 | DOI: 10.1111/j.1440-1843.2009.01638.x

      This study examined gender differences in the association between asthma and socioeconomic disadvantage using a representative population cohort. Asthma was associated with socioeconomic disadvantage but in socioeconomically advantaged groups, asthma prevalence was higher among women than men.

    6. Efficacy and safety of iodopovidone pleurodesis in malignant pleural effusions (pages 115–118)

      Jose D.A. NETO, Sandro F.Q. De OLIVEIRA, Sylvana P. VIANNA and Ricardo M. TERRA

      Version of Record online: 23 NOV 2009 | DOI: 10.1111/j.1440-1843.2009.01663.x

      This was a retrospective analysis of iodopovidone pleurodesis in patients with malignant pleural effusions. There was no recurrence of pleural fluid after iodopovidone pleurodesis. The most common complication was mild thoracic pain. Empyema occurred in one patient. Iodopovidone demonstrated good efficacy and safety, suggesting it is a useful alternative agent for pleurodesis.

    7. You have free access to this content
      Iodopovidone is as effective as doxycycline in producing pleurodesis in rabbits (pages 119–125)

      Yubiao GUO, Kejing TANG, Semra BILACEROGLU, Ioannis KALOMENIDIS, Kenneth J. SALLENG, Kirk B. LANE and Richard W. LIGHT

      Version of Record online: 27 DEC 2009 | DOI: 10.1111/j.1440-1843.2009.01671.x

      This study used a rabbit model to compare the effectiveness of iodopovidone in causing pleurodesis with that of doxycycline and investigated the mechanism by which iodopovine acts. Iodopovidone produced effective pleurodesis via an inflammatory mechanism and corticosteroids significantly decreased its efficacy.

    8. Differences in the clinical characteristics of Pneumocystis jirovecii pneumonia in immunocompromized patients with and without HIV infection (pages 126–131)

      Tatsuji ENOMOTO, Arata AZUMA, Ayumi KOHNO, Kazuyo KANEKO, Hitoshi SAITO, Minako KAMETAKA, Jiro USUKI, Akihiko GEMMA, Shoji KUDOH and Seiichi NAKAMURA

      Version of Record online: 23 NOV 2009 | DOI: 10.1111/j.1440-1843.2009.01660.x

      This retrospective study showed differences in the clinical characteristics and outcomes of PCP patients with and without HIV infection. CD4+ lymphocyte counts were significantly higher in HIV-negative PCP patients than in HIV-positive PCP patients; however, the mortality was higher in HIV-negative PCP patients despite earlier commencement of definitive treatment.

    9. Effects of antisense interleukin-5 gene transferred by recombinant adeno-associated virus to allergic rats (pages 132–140)

      Daxiong ZENG, Yong CAO, Qingfeng SONG, Chao CAO, Xiansheng LIU, Yongjian XU and Weining XIONG

      Version of Record online: 30 NOV 2009 | DOI: 10.1111/j.1440-1843.2009.01670.x

      An antisense IL-5 gene transferred by recombinant adeno-associated virus (rAAV-ASIL-5) was transfected into allergic rats. rAAV-ASIL-5 reduced the expression of IL-5, suppressed the recruitment and activation of eosinophils, decreased the levels of ECP, eotaxin and IgE and inhibited airway inflammation. rAAV-ASIL-5-based gene therapy may be useful in the treatment of allergic asthma.

    10. Population-based study of cystic fibrosis disease severity and haemochromatosis gene mutations (pages 141–149)

      Upasna PRATAP, Stephen QUINN, Leigh B. BLIZZARD and David W. REID

      Version of Record online: 27 DEC 2009 | DOI: 10.1111/j.1440-1843.2009.01649.x

      Disease outcomes in CF may be very variable despite identical genotypes, environments and infecting organisms. This study provides evidence to support a disease-modifying role for haemochromatosis gene mutations. These effects are most likely mediated through alterations in systemic iron homeostasis.

    11. Bronchoscopic features and bronchoscopic intervention for endobronchial hamartoma (pages 150–154)

      Su-A. KIM, Sang-Won UM, Jae-Uk SONG, Kyeongman JEON, Won-Jung KOH, Gee Young SUH, Man Pyo Jung, O. Jung KWON, Jong Heon PARK, Chin A. YI, Joungho HAN and Hojoong KIM

      Version of Record online: 23 NOV 2009 | DOI: 10.1111/j.1440-1843.2009.01662.x

      Typical findings of hamartoma, calcification and areas of focal fat were observed in 12.5% of study patients on chest CT. At bronchoscopy, most endobronchial hamartomas appeared as smooth surfaced round masses. Treatment by bronchoscopic resection was successful with minimal procedure-related complications.

    12. Ambient temperature impacts on pH of exhaled breath condensate (pages 155–159)

      Andreas R. KOCZULLA, Sarah NOESKE, Christian HERR, Frank DETTE, Olaf PINKENBURG, Severin SCHMID, Rudolf A. JÖRRES, Claus VOGELMEIER and Robert BALS

      Version of Record online: 23 NOV 2009 | DOI: 10.1111/j.1440-1843.2009.01664.x

      Analysis of EBC pH was performed in healthy controls, smokers before/after smoking and stable and exacerbated COPD patients. EBC pH was measured after degassing at 23°C and 37°C. pH values were significantly higher at 37°C. Thus it should be considered that the measurement temperature affects pH values of EBC.

  9. SHORT COMMUNICATIONS

    1. Top of page
    2. EDITORIALS
    3. INVITED REVIEW SERIES: COMPLICATIONS IN LUNG PROCEDURES
    4. INVITED REVIEW SERIES: PULMONARY FIBROSIS
    5. INVITED REVIEW SERIES: TUBERCULOSIS
    6. THINK TANK REVIEW
    7. PRO/CON DEBATE
    8. REVIEWS
    9. ORIGINAL ARTICLES
    10. SHORT COMMUNICATIONS
    11. TECHNICAL REPORT
    12. YEAR IN REVIEW
    13. CASE REPORTS
    14. FORTHCOMING MEETINGS/JOURNAL STATISTICS
    15. ACKNOWLEDGEMENTS
    1. CRP gene variation and risk of community-acquired pneumonia (pages 160–164)

      Kenneth J. MUKAMAL, Jennifer K. PAI, Ellen S. O'MEARA, Russell P. TRACY, Bruce M. PSATY, Lewis H. KULLER, Anne B. NEWMAN, Sachin YENDE, Gary C. CURHAN, David S. SISCOVICK and Eric B. RIMM

      Version of Record online: 23 NOV 2009 | DOI: 10.1111/j.1440-1843.2009.01661.x

      We tested whether variation in the CRP gene was associated with risk of pneumonia. We found that some genetic variants in CRP may be associated with risk of pneumonia, but not consistently in the manner expected from circulating CRP levels.

    2. Eosinopenia as a marker of mortality and length of stay in patients admitted with exacerbations of chronic obstructive pulmonary disease (pages 165–167)

      Mat HOLLAND, Mohammad ALKHALIL, Siram CHANDROMOULI, Ali JANJUA and Marta BABORES

      Version of Record online: 30 NOV 2009 | DOI: 10.1111/j.1440-1843.2009.01651.x

      We tested the utility of eosinopenia as a marker of mortality and length of stay in hospital inpatients admitted to hospital with exacerbations of COPD. Eosinopenia is shown to hold promise as a cheap marker of severity on admission inpatients hospitalized with exacerbations of COPD.

  10. TECHNICAL REPORT

    1. Top of page
    2. EDITORIALS
    3. INVITED REVIEW SERIES: COMPLICATIONS IN LUNG PROCEDURES
    4. INVITED REVIEW SERIES: PULMONARY FIBROSIS
    5. INVITED REVIEW SERIES: TUBERCULOSIS
    6. THINK TANK REVIEW
    7. PRO/CON DEBATE
    8. REVIEWS
    9. ORIGINAL ARTICLES
    10. SHORT COMMUNICATIONS
    11. TECHNICAL REPORT
    12. YEAR IN REVIEW
    13. CASE REPORTS
    14. FORTHCOMING MEETINGS/JOURNAL STATISTICS
    15. ACKNOWLEDGEMENTS
    1. Transbronchoscopic selective bronchial occlusion for intractable pneumothorax (pages 168–171)

      Yiming ZENG, Minli HONG, Huaping ZHANG, Dongyong YANG, Xiaoyang CHEN, Xibin ZUANG, Yunfeng CHENG, Jianhua GUAN and Qunyeng LIN

      Version of Record online: 5 NOV 2009 | DOI: 10.1111/j.1440-1843.2009.01650.x

      Transbronchoscopic balloon detection and selective bronchial occlusion were applied in the management of 40 patients with intractable pneumothorax. An autologous blood clot was used as a bronchial sealant. The efficacy of the procedure, effect on oxygenation and radiographic changes in occluded areas of the lung were evaluated.

  11. YEAR IN REVIEW

    1. Top of page
    2. EDITORIALS
    3. INVITED REVIEW SERIES: COMPLICATIONS IN LUNG PROCEDURES
    4. INVITED REVIEW SERIES: PULMONARY FIBROSIS
    5. INVITED REVIEW SERIES: TUBERCULOSIS
    6. THINK TANK REVIEW
    7. PRO/CON DEBATE
    8. REVIEWS
    9. ORIGINAL ARTICLES
    10. SHORT COMMUNICATIONS
    11. TECHNICAL REPORT
    12. YEAR IN REVIEW
    13. CASE REPORTS
    14. FORTHCOMING MEETINGS/JOURNAL STATISTICS
    15. ACKNOWLEDGEMENTS
    1. You have free access to this content
  12. CASE REPORTS

    1. Top of page
    2. EDITORIALS
    3. INVITED REVIEW SERIES: COMPLICATIONS IN LUNG PROCEDURES
    4. INVITED REVIEW SERIES: PULMONARY FIBROSIS
    5. INVITED REVIEW SERIES: TUBERCULOSIS
    6. THINK TANK REVIEW
    7. PRO/CON DEBATE
    8. REVIEWS
    9. ORIGINAL ARTICLES
    10. SHORT COMMUNICATIONS
    11. TECHNICAL REPORT
    12. YEAR IN REVIEW
    13. CASE REPORTS
    14. FORTHCOMING MEETINGS/JOURNAL STATISTICS
    15. ACKNOWLEDGEMENTS
    1. Aerosolized vancomycin for the treatment of MRSA after lung transplantation (pages 184–186)

      Don HAYES JR, Brian S. MURPHY, Timothy W. MULLETT and David J. FEOLA

      Version of Record online: 5 NOV 2009 | DOI: 10.1111/j.1440-1843.2009.01647.x

  13. FORTHCOMING MEETINGS/JOURNAL STATISTICS

    1. Top of page
    2. EDITORIALS
    3. INVITED REVIEW SERIES: COMPLICATIONS IN LUNG PROCEDURES
    4. INVITED REVIEW SERIES: PULMONARY FIBROSIS
    5. INVITED REVIEW SERIES: TUBERCULOSIS
    6. THINK TANK REVIEW
    7. PRO/CON DEBATE
    8. REVIEWS
    9. ORIGINAL ARTICLES
    10. SHORT COMMUNICATIONS
    11. TECHNICAL REPORT
    12. YEAR IN REVIEW
    13. CASE REPORTS
    14. FORTHCOMING MEETINGS/JOURNAL STATISTICS
    15. ACKNOWLEDGEMENTS
    1. FORTHCOMING MEETINGS (page 187)

      Version of Record online: 27 DEC 2009 | DOI: 10.1111/j.1440-1843.2009.01694_1.x

    2. JOURNAL STATISTICS (page 187)

      Version of Record online: 27 DEC 2009 | DOI: 10.1111/j.1440-1843.2009.01694_2.x

  14. ACKNOWLEDGEMENTS

    1. Top of page
    2. EDITORIALS
    3. INVITED REVIEW SERIES: COMPLICATIONS IN LUNG PROCEDURES
    4. INVITED REVIEW SERIES: PULMONARY FIBROSIS
    5. INVITED REVIEW SERIES: TUBERCULOSIS
    6. THINK TANK REVIEW
    7. PRO/CON DEBATE
    8. REVIEWS
    9. ORIGINAL ARTICLES
    10. SHORT COMMUNICATIONS
    11. TECHNICAL REPORT
    12. YEAR IN REVIEW
    13. CASE REPORTS
    14. FORTHCOMING MEETINGS/JOURNAL STATISTICS
    15. ACKNOWLEDGEMENTS

SEARCH

SEARCH BY CITATION